Consolidated Statement of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ 9,917,273	$ 20,527,192	$ (21,830,682)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities -
Depreciation and amortization	642,358	166,990	3,161,090
Amortization of beneficial conversion features	0	0	918,710
Amortization of warrants	0	0	673,852
Gain on sale of STRIANT	0	(2,533,127)	0
Change in value of redeemable warrants	0	2,721,205	7,961,939
Change in value of stock warrants	(6,995,099)	(556,662)	5,229,089
Recognition of deferred income	0	(17,113,404)	(17,366,829)
Loss on extinguishment of debt	0	0	5,156,775
(Credit) provision for doubtful accounts	0	0	59,297
Provision for sales returns	(625,452)	358,287	1,781,617
Write-down of inventories	970,419	58,612	41,311
Write-off of accounts receivable	0	7,616	0
Share based compensation	668,392	814,520	2,800,256
Non-cash interest expense on financing agreements	0	0	1,137,222
Write-down of impaired assets	889,869	0	0
Loss on disposal of fixed assets	7,547	3,780	0
Changes in assets and liabilities-(Increase) decrease in:
Accounts receivable	1,272,757	(562,000)	62,529
Inventories	38,705	(1,396,167)	(94,796)
Prepaid expenses and other current assets	(616,352)	(275,017)	599,578
Other assets	425,404	19,855	(995)
Increase (decrease) in:
Accounts payable	(2,021,494)	(1,867,795)	1,731,875
Accrued expenses	(217,572)	(1,838,756)	(1,870,466)
Deferred revenue	(12,890)	125,000	125,000
Net cash provided by (used in) operating activities	4,343,865	(1,339,871)	(9,723,628)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(985,930)	(1,307,103)	(42,393)
Additions to short term investments	(234,767)	(15,101,980)	0
Proceeds from sale of assets	0	0	35,240,000
Proceeds from the sale of STRIANT	0	3,100,000	0
Net cash (used in) provided by investing activities	(1,220,697)	(13,309,083)	35,197,607
CASH FLOWS FROM FINANCING ACTIVITIES:
Redemption of series C convertible preferred stock	(50,000)	0	0
Net proceeds from issuance of common stock and warrants	0	0	11,643,897
Proceeds from financing agreements - Actavis Note	0	0	15,000,000
Payment of note payable	0	0	(25,999,999)
Proceeds from exercise of stock options	0	2,641,950	79,148
Proceeds from exercise of warrants	0	653,299	0
Repurchase of company stock	0	0	(3,059,997)
Payment pursuant to financing agreements	0	0	(16,155,903)
Payments for the purchase of treasury stock	0	(125,381)	(62,280)
Dividends paid	(29,334)	(30,000)	(30,000)
Net cash (used in) provided by financing activities	(79,334)	3,139,868	(18,585,134)
EFFECT OF EXCHANGE RATE CHANGES ON CASH	46,070	(7,730)	(15,481)
NET INCREASE/(DECREASE) IN CASH AND CASH EQUIVALENTS	3,089,904	(11,516,816)	6,873,364
CASH AND CASH EQUIVALENTS, Beginning of year	10,114,163	21,630,979	14,757,615
CASH AND CASH EQUIVALENTS, End of year	13,204,067	10,114,163	21,630,979
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Interest paid	0	0	1,608,889
Taxes paid	0	220,042	77,199
NON-CASH INVESTING & FINANCING ACTIVITIES
Reclassification of redeemable warrant liability to capital in excess of par value	0	16,193,037	0
Retirement of warrant liability	0	561,398	0
Forgiveness of Actavis Note	0	0	15,000,000
Net Issuance of Common Stock for Debt Retirement	0	0	7,738,883
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants	$ 0	$ 0	$ 5,509,893